Contact / Partner with gNu

Bring us your
hardest injection.

One architecture. A development program shaped around your challenge.

We are engaging with pharmaceutical companies, device partners, computational engineers and investors who want to rethink physical drug delivery.

Start a conversation

Define what
comes next.

A short introduction is enough. Tell us what you are working on and where gNu might fit.

Company & investment

David Widom

david@gnucompany.com ↗

Physical engineering

Steven Opolski

steven@gnucompany.com ↗
Your introductionAll fields required

Opens a draft in your email app for you to review and send. Nothing is submitted through this preview.

A focused first program

The first product
is evidence.

Our near-term objective is a defined intramuscular candidate evaluated for flow, penetration, structural margin and delivery at depth—with predictions compared against physical measurements.

Explore the development roadmap ↗